 | • レポートコード：QAF27873 • 出版社/出版日：QYResearch / 2021年3月31日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のレニン阻害剤市場について種類別（150mg/錠、300mg/錠）、用途別（45歳以下、45〜55歳、55〜65歳、65歳以上）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・レニン阻害剤市場の概要 ・世界の主要地域別レニン阻害剤市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のレニン阻害剤市場規模2016-2021：種類別（150mg/錠、300mg/錠） ・世界のレニン阻害剤市場予測2012-2027：種類別（150mg/錠、300mg/錠） ・世界のレニン阻害剤市場規模2016-2021：用途別（45歳以下、45〜55歳、55〜65歳、65歳以上） ・世界のレニン阻害剤市場予測2012-2027：用途別（45歳以下、45〜55歳、55〜65歳、65歳以上） ・レニン阻害剤のアメリカ市場規模と予測2016-2021 ・レニン阻害剤のヨーロッパ市場規模と予測2016-2021 ・レニン阻害剤の中国市場規模と予測2016-2021 ・レニン阻害剤の日本市場規模と予測2016-2021 ・レニン阻害剤の東南アジア市場規模と予測2016-2021 ・レニン阻害剤のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Novartis、Noden Pharma） ・レニン阻害剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・レニン阻害剤の市場動向・機会・課題 ・調査の結論 |
Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the kidneys in response to sympathetic activation, hypotension, and decreased sodium delivery to the distal renal tubule. Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.
USA is still the largest consumption region of Tekturna, occupied about 56% market share globally, with revenue 39.21 million USD in 2017. At the same time, Asia will see the considerable growth since Noden Pharma DAC had successfully entered into an agreement with Orphan Pacific (Japan) and Lee’s Pharmaceutical Holdings Limited (China).
Market Analysis and Insights: Global Renin-Inhibitors Market
The global Renin-Inhibitors market was valued at US$ 91 in 2020 and will reach US$ 135.3 million by the end of 2027, growing at a CAGR of 6.8% during 2022-2027.
Global Renin-Inhibitors Scope and Market Size
The global Renin-Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Renin-Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
150mg/Tablet
300mg/Tablet
Segment by Application
Age below 45
Age 45-55
Age 55-65
Age above 65
The Renin-Inhibitors market is analysed and market size information is provided by regions (countries). Segment by Application, the Renin-Inhibitors market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Novartis
Noden Pharma
1 Renin-Inhibitors Market Overview
1.1 Renin-Inhibitors Product Scope
1.2 Renin-Inhibitors Segment by Type
1.2.1 Global Renin-Inhibitors Sales by Type (2016 & 2021 & 2027)
1.2.2 150mg/Tablet
1.2.3 300mg/Tablet
1.3 Renin-Inhibitors Segment by Application
1.3.1 Global Renin-Inhibitors Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Age below 45
1.3.3 Age 45-55
1.3.4 Age 55-65
1.3.5 Age above 65
1.4 Renin-Inhibitors Market Estimates and Forecasts (2016-2027)
1.4.1 Global Renin-Inhibitors Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Renin-Inhibitors Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Renin-Inhibitors Price Trends (2016-2027)
2 Renin-Inhibitors Estimates and Forecasts by Region
2.1 Global Renin-Inhibitors Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Renin-Inhibitors Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Renin-Inhibitors Sales Market Share by Region (2016-2021)
2.2.2 Global Renin-Inhibitors Revenue Market Share by Region (2016-2021)
2.3 Global Renin-Inhibitors Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Renin-Inhibitors Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Renin-Inhibitors Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Renin-Inhibitors Estimates and Projections (2016-2027)
2.4.2 Europe Renin-Inhibitors Estimates and Projections (2016-2027)
2.4.3 China Renin-Inhibitors Estimates and Projections (2016-2027)
2.4.4 Japan Renin-Inhibitors Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Renin-Inhibitors Estimates and Projections (2016-2027)
2.4.6 India Renin-Inhibitors Estimates and Projections (2016-2027)
3 Global Renin-Inhibitors Competition Landscape by Players
3.1 Global Top Renin-Inhibitors Players by Sales (2016-2021)
3.2 Global Top Renin-Inhibitors Players by Revenue (2016-2021)
3.3 Global Renin-Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Renin-Inhibitors as of 2020)
3.4 Global Renin-Inhibitors Average Price by Company (2016-2021)
3.5 Manufacturers Renin-Inhibitors Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Renin-Inhibitors Market Size by Type
4.1 Global Renin-Inhibitors Historic Market Review by Type (2016-2021)
4.1.1 Global Renin-Inhibitors Sales Market Share by Type (2016-2021)
4.1.2 Global Renin-Inhibitors Revenue Market Share by Type (2016-2021)
4.1.3 Global Renin-Inhibitors Price by Type (2016-2021)
4.2 Global Renin-Inhibitors Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Renin-Inhibitors Sales Forecast by Type (2022-2027)
4.2.2 Global Renin-Inhibitors Revenue Forecast by Type (2022-2027)
4.2.3 Global Renin-Inhibitors Price Forecast by Type (2022-2027)
5 Global Renin-Inhibitors Market Size by Application
5.1 Global Renin-Inhibitors Historic Market Review by Application (2016-2021)
5.1.1 Global Renin-Inhibitors Sales Market Share by Application (2016-2021)
5.1.2 Global Renin-Inhibitors Revenue Market Share by Application (2016-2021)
5.1.3 Global Renin-Inhibitors Price by Application (2016-2021)
5.2 Global Renin-Inhibitors Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Renin-Inhibitors Sales Forecast by Application (2022-2027)
5.2.2 Global Renin-Inhibitors Revenue Forecast by Application (2022-2027)
5.2.3 Global Renin-Inhibitors Price Forecast by Application (2022-2027)
6 North America Renin-Inhibitors Market Facts & Figures
6.1 North America Renin-Inhibitors Sales by Company
6.1.1 North America Renin-Inhibitors Sales by Company (2016-2021)
6.1.2 North America Renin-Inhibitors Revenue by Company (2016-2021)
6.2 North America Renin-Inhibitors Sales Breakdown by Type
6.2.1 North America Renin-Inhibitors Sales Breakdown by Type (2016-2021)
6.2.2 North America Renin-Inhibitors Sales Breakdown by Type (2022-2027)
6.3 North America Renin-Inhibitors Sales Breakdown by Application
6.3.1 North America Renin-Inhibitors Sales Breakdown by Application (2016-2021)
6.3.2 North America Renin-Inhibitors Sales Breakdown by Application (2022-2027)
7 Europe Renin-Inhibitors Market Facts & Figures
7.1 Europe Renin-Inhibitors Sales by Company
7.1.1 Europe Renin-Inhibitors Sales by Company (2016-2021)
7.1.2 Europe Renin-Inhibitors Revenue by Company (2016-2021)
7.2 Europe Renin-Inhibitors Sales Breakdown by Type
7.2.1 Europe Renin-Inhibitors Sales Breakdown by Type (2016-2021)
7.2.2 Europe Renin-Inhibitors Sales Breakdown by Type (2022-2027)
7.3 Europe Renin-Inhibitors Sales Breakdown by Application
7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)
8 China Renin-Inhibitors Market Facts & Figures
8.1 China Renin-Inhibitors Sales by Company
8.1.1 China Renin-Inhibitors Sales by Company (2016-2021)
8.1.2 China Renin-Inhibitors Revenue by Company (2016-2021)
8.2 China Renin-Inhibitors Sales Breakdown by Type
8.2.1 China Renin-Inhibitors Sales Breakdown by Type (2016-2021)
8.2.2 China Renin-Inhibitors Sales Breakdown by Type (2022-2027)
8.3 China Renin-Inhibitors Sales Breakdown by Application
8.3.1 China 243 Sales Breakdown by Application (2016-2021)
8.3.2 China 243 Sales Breakdown by Application (2022-2027)
9 Japan Renin-Inhibitors Market Facts & Figures
9.1 Japan Renin-Inhibitors Sales by Company
9.1.1 Japan Renin-Inhibitors Sales by Company (2016-2021)
9.1.2 Japan Renin-Inhibitors Revenue by Company (2016-2021)
9.2 Japan Renin-Inhibitors Sales Breakdown by Type
9.2.1 Japan Renin-Inhibitors Sales Breakdown by Type (2016-2021)
9.2.2 Japan Renin-Inhibitors Sales Breakdown by Type (2022-2027)
9.3 Japan Renin-Inhibitors Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Renin-Inhibitors Market Facts & Figures
10.1 Southeast Asia Renin-Inhibitors Sales by Company
10.1.1 Southeast Asia Renin-Inhibitors Sales by Company (2016-2021)
10.1.2 Southeast Asia Renin-Inhibitors Revenue by Company (2016-2021)
10.2 Southeast Asia Renin-Inhibitors Sales Breakdown by Type
10.2.1 Southeast Asia Renin-Inhibitors Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Renin-Inhibitors Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Renin-Inhibitors Sales Breakdown by Application
10.3.1 Southeast Asia K Tablet Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Tablet Sales Breakdown by Application (2022-2027)
11 India Renin-Inhibitors Market Facts & Figures
11.1 India Renin-Inhibitors Sales by Company
11.1.1 India Renin-Inhibitors Sales by Company (2016-2021)
11.1.2 India Renin-Inhibitors Revenue by Company (2016-2021)
11.2 India Renin-Inhibitors Sales Breakdown by Type
11.2.1 India Renin-Inhibitors Sales Breakdown by Type (2016-2021)
11.2.2 India Renin-Inhibitors Sales Breakdown by Type (2022-2027)
11.3 India Renin-Inhibitors Sales Breakdown by Application
11.3.1 India Renin-Inhibitors Sales Breakdown by Application (2016-2021)
11.3.2 India Renin-Inhibitors Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Renin-Inhibitors Business
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Business Overview
12.1.3 Novartis Renin-Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Renin-Inhibitors Products Offered
12.1.5 Novartis Recent Development
12.2 Noden Pharma
12.2.1 Noden Pharma Corporation Information
12.2.2 Noden Pharma Business Overview
12.2.3 Noden Pharma Renin-Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Noden Pharma Renin-Inhibitors Products Offered
12.2.5 Noden Pharma Recent Development
…
13 Renin-Inhibitors Manufacturing Cost Analysis
13.1 Renin-Inhibitors Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Renin-Inhibitors
13.4 Renin-Inhibitors Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Renin-Inhibitors Distributors List
14.3 Renin-Inhibitors Customers
15 Market Dynamics
15.1 Renin-Inhibitors Market Trends
15.2 Renin-Inhibitors Drivers
15.3 Renin-Inhibitors Market Challenges
15.4 Renin-Inhibitors Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Renin-Inhibitors Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Renin-Inhibitors Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Renin-Inhibitors Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Renin-Inhibitors Sales (K Tablet) by Region (2016-2021)
Table 5. Global Renin-Inhibitors Sales Market Share by Region (2016-2021)
Table 6. Global Renin-Inhibitors Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Renin-Inhibitors Revenue Share by Region (2016-2021)
Table 8. Global Renin-Inhibitors Sales (K Tablet) Forecast by Region (2022-2027)
Table 9. Global Renin-Inhibitors Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Renin-Inhibitors Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Renin-Inhibitors Revenue Share Forecast by Region (2022-2027)
Table 12. Global Renin-Inhibitors Sales (K Tablet) of Key Companies (2016-2021)
Table 13. Global Renin-Inhibitors Sales Share by Company (2016-2021)
Table 14. Global Renin-Inhibitors Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Renin-Inhibitors Revenue Share by Company (2016-2021)
Table 16. Global Renin-Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renin-Inhibitors as of 2020)
Table 17. Global Renin-Inhibitors Average Price (USD/K Tablet) of Key Company (2016-2021)
Table 18. Manufacturers Renin-Inhibitors Manufacturing Sites and Area Served
Table 19. Manufacturers Renin-Inhibitors Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Renin-Inhibitors Sales (K Tablet) by Type (2016-2021)
Table 22. Global Renin-Inhibitors Sales Share by Type (2016-2021)
Table 23. Global Renin-Inhibitors Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Renin-Inhibitors Price (USD/K Tablet) by Type (2016-2021)
Table 25. Global Renin-Inhibitors Sales Share by Type (2022-2027)
Table 26. Global Renin-Inhibitors Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Renin-Inhibitors Revenue Share by Type (2022-2027)
Table 28. Global Renin-Inhibitors Price (USD/K Tablet) by Type (2022-2027)
Table 29. Global Renin-Inhibitors Sales (K Tablet) by Application (2016-2021)
Table 30. Global Renin-Inhibitors Sales Share by Application (2016-2021)
Table 31. Global Renin-Inhibitors Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Renin-Inhibitors Price (USD/K Tablet) by Application (2016-2021)
Table 33. Global Renin-Inhibitors Sales (K Tablet) by Application (2022-2027)
Table 34. Global Renin-Inhibitors Sales Share by Application (2022-2027)
Table 35. Global Renin-Inhibitors Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Renin-Inhibitors Revenue Share by Application (2022-2027)
Table 37. Global Renin-Inhibitors Price (USD/K Tablet) by Application (2022-2027)
Table 38. North America Renin-Inhibitors Sales (K Tablet) by Company (2016-2021)
Table 39. North America Renin-Inhibitors Sales Market Share by Company (2016-2021)
Table 40. North America Renin-Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Renin-Inhibitors Revenue Market Share by Company (2016-2021)
Table 42. North America Renin-Inhibitors Sales by Type (2016-2021) & (K Tablet)
Table 43. North America Renin-Inhibitors Sales Market Share by Type (2016-2021)
Table 44. North America Renin-Inhibitors Sales by Type (2022-2027) & (K Tablet)
Table 45. North America Renin-Inhibitors Sales Market Share by Type (2022-2027)
Table 46. North America Renin-Inhibitors Sales by Application (2016-2021) & (K Tablet)
Table 47. North America Renin-Inhibitors Sales Market Share by Application (2016-2021)
Table 48. North America Renin-Inhibitors Sales by Application (2022-2027) & (K Tablet)
Table 49. North America Renin-Inhibitors Sales Market Share by Application (2022-2027)
Table 50. Europe Renin-Inhibitors Sales (K Tablet) by Company (2016-2021)
Table 51. Europe Renin-Inhibitors Sales Market Share by Company (2016-2021)
Table 52. Europe Renin-Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Renin-Inhibitors Revenue Market Share by Company (2016-2021)
Table 54. Europe Renin-Inhibitors Sales by Type (2016-2021) & (K Tablet)
Table 55. Europe Renin-Inhibitors Sales Market Share by Type (2016-2021)
Table 56. Europe Renin-Inhibitors Sales by Type (2022-2027) & (K Tablet)
Table 57. Europe Renin-Inhibitors Sales Market Share by Type (2022-2027)
Table 58. Europe Renin-Inhibitors Sales by Application (2016-2021) & (K Tablet)
Table 59. Europe Renin-Inhibitors Sales Market Share by Application (2016-2021)
Table 60. Europe Renin-Inhibitors Sales by Application (2022-2027) & (K Tablet)
Table 61. Europe Renin-Inhibitors Sales Market Share by Application (2022-2027)
Table 62. China Renin-Inhibitors Sales (K Tablet) by Company (2016-2021)
Table 63. China Renin-Inhibitors Sales Market Share by Company (2016-2021)
Table 64. China Renin-Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Renin-Inhibitors Revenue Market Share by Company (2016-2021)
Table 66. China Renin-Inhibitors Sales by Type (2016-2021) & (K Tablet)
Table 67. China Renin-Inhibitors Sales Market Share by Type (2016-2021)
Table 68. China Renin-Inhibitors Sales by Type (2022-2027) & (K Tablet)
Table 69. China Renin-Inhibitors Sales Market Share by Type (2022-2027)
Table 70. China Renin-Inhibitors Sales by Application (2016-2021) & (K Tablet)
Table 71. China Renin-Inhibitors Sales Market Share by Application (2016-2021)
Table 72. China Renin-Inhibitors Sales by Application (2022-2027) & (K Tablet)
Table 73. China Renin-Inhibitors Sales Market Share by Application (2022-2027)
Table 74. Japan Renin-Inhibitors Sales (K Tablet) by Company (2016-2021)
Table 75. Japan Renin-Inhibitors Sales Market Share by Company (2016-2021)
Table 76. Japan Renin-Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Renin-Inhibitors Revenue Market Share by Company (2016-2021)
Table 78. Japan Renin-Inhibitors Sales by Type (2016-2021) & (K Tablet)
Table 79. Japan Renin-Inhibitors Sales Market Share by Type (2016-2021)
Table 80. Japan Renin-Inhibitors Sales by Type (2022-2027) & (K Tablet)
Table 81. Japan Renin-Inhibitors Sales Market Share by Type (2022-2027)
Table 82. Japan Renin-Inhibitors Sales by Application (2016-2021) & (K Tablet)
Table 83. Japan Renin-Inhibitors Sales Market Share by Application (2016-2021)
Table 84. Japan Renin-Inhibitors Sales by Application (2022-2027) & (K Tablet)
Table 85. Japan Renin-Inhibitors Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Renin-Inhibitors Sales (K Tablet) by Company (2016-2021)
Table 87. Southeast Asia Renin-Inhibitors Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Renin-Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Renin-Inhibitors Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Renin-Inhibitors Sales by Type (2016-2021) & (K Tablet)
Table 91. Southeast Asia Renin-Inhibitors Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Renin-Inhibitors Sales by Type (2022-2027) & (K Tablet)
Table 93. Southeast Asia Renin-Inhibitors Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Renin-Inhibitors Sales by Application (2016-2021) & (K Tablet)
Table 95. Southeast Asia Renin-Inhibitors Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Renin-Inhibitors Sales by Application (2022-2027) & (K Tablet)
Table 97. Southeast Asia Renin-Inhibitors Sales Market Share by Application (2022-2027)
Table 98. India Renin-Inhibitors Sales (K Tablet) by Company (2016-2021)
Table 99. India Renin-Inhibitors Sales Market Share by Company (2016-2021)
Table 100. India Renin-Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Renin-Inhibitors Revenue Market Share by Company (2016-2021)
Table 102. India Renin-Inhibitors Sales by Type (2016-2021) & (K Tablet)
Table 103. India Renin-Inhibitors Sales Market Share by Type (2016-2021)
Table 104. India Renin-Inhibitors Sales by Type (2022-2027) & (K Tablet)
Table 105. India Renin-Inhibitors Sales Market Share by Type (2022-2027)
Table 106. India Renin-Inhibitors Sales by Application (2016-2021) & (K Tablet)
Table 107. India Renin-Inhibitors Sales Market Share by Application (2016-2021)
Table 108. India Renin-Inhibitors Sales by Application (2022-2027) & (K Tablet)
Table 109. India Renin-Inhibitors Sales Market Share by Application (2022-2027)
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Renin-Inhibitors Sales (K Tablet), Revenue (Million USD), Price (USD/K Tablet) and Gross Margin (2016-2021)
Table 113. Novartis Renin-Inhibitors Product
Table 114. Novartis Recent Development
Table 115. Noden Pharma Corporation Information
Table 116. Noden Pharma Description and Business Overview
Table 117. Noden Pharma Renin-Inhibitors Sales (K Tablet), Revenue (Million USD), Price (USD/K Tablet) and Gross Margin (2016-2021)
Table 118. Noden Pharma Renin-Inhibitors Product
Table 119. Noden Pharma Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Renin-Inhibitors Distributors List
Table 123. Renin-Inhibitors Customers List
Table 124. Renin-Inhibitors Market Trends
Table 125. Renin-Inhibitors Market Drivers
Table 126. Renin-Inhibitors Market Challenges
Table 127. Renin-Inhibitors Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Renin-Inhibitors Product Picture
Figure 2. Global Renin-Inhibitors Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Renin-Inhibitors Sales Market Share by Application in 2021 & 2027
Figure 6. Age below 45 Examples
Figure 7. Age 45-55 Examples
Figure 8. Age 55-65 Examples
Figure 9. Age above 65 Examples
Figure 10. Global Renin-Inhibitors Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Renin-Inhibitors Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Renin-Inhibitors Sales (K Tablet) Growth Rate (2016-2027)
Figure 13. Global Renin-Inhibitors Price Trends Growth Rate (2016-2027) (USD/K Tablet)
Figure 14. Global Renin-Inhibitors Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Renin-Inhibitors Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Renin-Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Renin-Inhibitors Sales (K Tablet) Growth Rate (2016-2027)
Figure 18. Europe Renin-Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Renin-Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Renin-Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Renin-Inhibitors Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Renin-Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Renin-Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Renin-Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Renin-Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Renin-Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Renin-Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Renin-Inhibitors Players Market Share by Revenue in Renin-Inhibitors: 2016 & 2020
Figure 29. Renin-Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Renin-Inhibitors Revenue Share by Type (2016-2021)
Figure 31. Global Renin-Inhibitors Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Renin-Inhibitors Revenue Share by Application (2016-2021)
Figure 33. Global Renin-Inhibitors Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Renin-Inhibitors Sales Market Share by Type in 2020
Figure 35. North America Renin-Inhibitors Sales Market Share by Application in 2020
Figure 36. Europe Renin-Inhibitors Sales Market Share by Type in 2020
Figure 37. Europe Renin-Inhibitors Sales Market Share by Application in 2020
Figure 38. China Renin-Inhibitors Sales Market Share by Type in 2020
Figure 39. China Renin-Inhibitors Sales Market Share by Application in 2020
Figure 40. Japan Renin-Inhibitors Sales Market Share by Type in 2020
Figure 41. Japan Renin-Inhibitors Sales Market Share by Application in 2020
Figure 42. Southeast Asia Renin-Inhibitors Sales Market Share by Type in 2020
Figure 43. Southeast Asia Renin-Inhibitors Sales Market Share by Application in 2020
Figure 44. India Renin-Inhibitors Sales Market Share by Type in 2020
Figure 45. India Renin-Inhibitors Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Renin-Inhibitors
Figure 48. Manufacturing Process Analysis of Renin-Inhibitors
Figure 49. Renin-Inhibitors Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
世界のBCL-2（B細胞リンパ腫2）阻害剤市場規模・現状・予測（2021年-2027年） Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis. Market Analysis and Insights: Global BCL-2 (B-cell lympho…- 世界の副腎皮質ホルモン阻害剤市場規模・現状・予測（2021年-2027年） Adrenal corticosteroid inhibitors are a class of therapeutic drugs that are widely used to treat Cushing's syndrome and certain types of solid tumors, such as breast cancer. It exerts its effect by inhibiting the endogenous synthesis of hormones secreted by the adrenal cortex by interfering with the…
- 世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年） Neuraminidase Inhibitors (NAIs) are the type of drugs that are used to block the neuraminidase enzyme. Market Analysis and Insights: Global Neuraminidase Inhibitors Drug Market The global Neuraminidase Inhibitors Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2…
- 世界のヤヌスキナーゼ（JAK）阻害剤市場規模・現状・予測（2021年-2027年） JAK inhibitors are increasingly being used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis because of its proven efficacy in the treatment of various chronic diseases. The high unmet need for the treatment of graft-versus-host disease (GVHD) has also encouraged market vend…
- 世界のヘッジホッグ経路阻害剤市場規模・現状・予測（2021年-2027年） Hedgehog pathway inhibitors are small molecules that inhibit the activity of a component of the Hedgehog signaling pathway. Market Analysis and Insights: Global Hedgehog Pathway Inhibitors Market The global Hedgehog Pathway Inhibitors market size is projected to reach US$ XX million by 2027, from US…